Holtzman DM, Morris JC, Goate AM. Alzheimer’s disease: the challenge of the second century. Sci Transl Med. 2011;3:77sr71.

Article  Google Scholar 

Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Prim. 2021;7:33.

Article  PubMed  Google Scholar 

Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol. 2014;6:37–48.

Article  PubMed  PubMed Central  Google Scholar 

Alzheimer’s Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement 2015;11:332–84.

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.

Article  PubMed  Google Scholar 

Nasca C, Bigio B, Zelli D, de Angelis P, Lau T, Okamoto M, et al. Role of the astroglial glutamate exchanger xCT in ventral hippocampus in resilience to stress. Neuron. 2017;96:402–413.e405.

Article  CAS  PubMed  Google Scholar 

Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, et al. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci USA. 2013;110:4804–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuccurazzu B, Bortolotto V, Valente MM, Ubezio F, Koverech A, Canonico PL, et al. Upregulation of mGlu2 receptors via NF-kappaB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine. Neuropsychopharmacology. 2013;38:2220–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bigio B, Mathe AA, Sousa VC, Zelli D, Svenningsson P, McEwen BS, et al. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance. Proc Natl Acad Sci USA. 2016;113:7906–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morrison JH, Hof PR. Chapter 37 Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer’s disease. Prog Brain Res. 2002;136:467–86.

Article  CAS  PubMed  Google Scholar 

Fritz IB, McEwen BS. Effects of carnitine on fatty-acid oxidation by muscle. Science. 1959;129:334–5.

Article  CAS  PubMed  Google Scholar 

Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry. 2000;5:616–32.

Article  CAS  PubMed  Google Scholar 

Barnes CA, Markowska AL, Ingram DK, Kametani H, Spangler EL, Lemken VJ, et al. Acetyl-1-carnitine. 2: Effects on learning and memory performance of aged rats in simple and complex mazes. Neurobiol Aging. 1990;11:499–506.

Article  CAS  PubMed  Google Scholar 

Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci USA. 2002;99:2356–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Head E, Kuratsune H, Cotman CW, Ames BN. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann N Y Acad Sci. 2004;1033:117–31.

Article  CAS  PubMed  Google Scholar 

Gräff J, Tsai LH. Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci. 2013;14:97–111.

Article  PubMed  Google Scholar 

Janczura KJ, Volmar CH, Sartor GC, Rao SJ, Ricciardi NR, Lambert G, et al. Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model. Proc Natl Acad Sci USA. 2018;115:E11148–e11157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robinson DM, Keating GM. Memantine: a review of its use in Alzheimer’s disease. Drugs. 2006;66:1515–34.

Article  CAS  PubMed  Google Scholar 

Nestler EJ, Peña CJ, Kundakovic M, Mitchell A, Akbarian S. Epigenetic basis of mental illness. Neuroscientist. 2016;22:447–63.

Article  CAS  PubMed  Google Scholar 

Herzog CJ, Miot S, Mansuy IM, Giros B, Tzavara ET. Chronic valproate normalizes behavior in mice overexpressing calcineurin. Eur J Pharmacol. 2008;580:153–60.

Article  CAS  PubMed  Google Scholar 

Eriksson TM, Delagrange P, Spedding M, Popoli M, Mathé AA, Ögren SO, et al. Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry. 2012;17:173–84.

Article  CAS  PubMed  Google Scholar 

Nasca C, Dobbin J, Bigio B, Watson K, de Angelis P, Kautz M, et al. Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance. Mol Psychiatry. 2021;26:5140–49.

De Felice FG, Gonçalves RA, Ferreira ST. Impaired insulin signalling and allostatic load in Alzheimer disease. Nat Rev Neurosci. 2022;23:215–30.

Article  PubMed  Google Scholar 

De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, et al. Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA. 2009;106:1971–6.

Article  PubMed  PubMed Central  Google Scholar 

Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG. Insulin resistance in Alzheimer’s disease. Front Neurosci. 2018;12:830.

Biessels GJ, Reagan LP. Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci. 2015;16:660–71.

Article  CAS  PubMed  Google Scholar 

Nasca C, Bigio B, Lee FS, Young SP, Kautz MM, Albright A, et al. Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci USA. 2018;115:8627–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiraly DD, Horn SR, Van Dam NT, Costi S, Schwartz J, Kim-Schulze S, et al. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl Psychiatry. 2017;7:e1065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Post RM. Myriad of implications of acetyl-l-carnitine deficits in depression. Proc Natl Acad Sci USA. 2018;115:8475–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pfau ML, Russo SJ. Neuroinflammation regulates cognitive impairment in socially defeated mice. Trends Neurosci. 2016;39:353–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rasgon NL, McEwen BS. Insulin resistance-a missing link no more. Mol Psychiatry. 2016;21:1648–52.

Article  CAS  PubMed  Google Scholar 

Cristofano A, Sapere N, La Marca G, Angiolillo A, Vitale M, Corbi G, et al. Serum levels of Acyl-carnitines along the continuum from normal to Alzheimer’s dementia. PLoS ONE. 2016;11:e0155694.

Article  PubMed  PubMed Central  Google Scholar 

Spagnoli A, Lucca U, Menasce G, Bandera L, Cizza G, Forloni G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer’s disease. Neurology. 1991;41:1726–32.

Article  CAS  PubMed